Indian multinational pharmaceutical company
Cadila Healthcare ▸ Facts ▸ Comments ▸ News ▸ Videos
What is Virafin? How does the Zydus Cadila drug work? | Oneindia News
Credit: Oneindia Duration: 01:24Published
Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases
Credit: ANI Duration: 02:01Published
You Might Like
Zydus Cadila's Virafin granted restricted emergency use approval for treating Covid patients: DBT
Also reported by •DNA
Zydus Cadila Healthcare starts producing Covid-19 vaccine
Zydus Cadila gets DCGI nod for hepatitis drug for Covid-19 treatmentDrug firm Zydus Cadila on Friday said it has received restricted emergency use approval from the Indian drug regulator for the use of Pegylated Interferon alpha-2b (PegIFN) in treating moderate..
Zydus vaccine to cover children too
Companies set to double Remdesivir outputEven as the Centre announced a slew of measures to improve access of Covid-19 therapy, Remdesivir, major players including Zydus Cadila, Cipla, Mylan and Dr Reddy’s are ramping up production, which..
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical trial of its novel molecule ZYIL1, indicated for use as an..
Covid-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy
Gujarat: PM Modi reviews vaccine development at Zydus Cadila facilityPrime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad. After..
PM Modi reaches Ahmedabad to review coronavirus vaccine developmentPrime Minister Narendra Modi landed here on Saturday as part of his three-city visit to ireview coronavirus vaccine development work at facilities there, an official said. From the airport, Modi..
PM to visit Zydus' Covid-19 vaccine development centre in Gujarat
PM to visit vaccine centres in 3 citiesWhile in Hyderabad, the PM will visit vaccine maker Bharat Biotech’s facilities, where work on the development of India’s first indigenous Covid-19 vaccine, Covaxin, is under way, he will drop in..
India to get COVID-19 vaccine by mid-2021, says Biocon's Kiran Mazumdar-ShawBesides, Bharat Biotech, Zydus Cadila Ltd is also in Phase 2 of human clinical trials of a COVID-19 vaccine.
For high-risk groups, government plans to fast-track vaccineIndia has three vaccines in advanced stages of trial. The vaccine candidate developed by Oxford University and AstraZeneca and proposed in India by Serum Institute is ahead and is set to enter phase 3...
Covid-19 vaccine: Govt panel meets representatives of leading domestic manufacturersThe national expert group on vaccine administration for Covid-19 met representatives of leading domestic manufactures, including Serum Institute of India, Bharat Biotech and Zydus Cadila, on Monday to..
National Expert Group discusses vaccine development with domestic manufacturesNational Expert Group on Vaccine Administration on Monday met leading domestic vaccine manufactures- Serum Institute of India, Pune; Bharat Biotech, Hyderabad; Zydus Cadila, Ahmedabad; Gennova..
Zydus' 'budget' injection costs 2,800/shotAhmedabad-based Zydus Cadila announced the launch of its anti-viral Remdesivir drug at Rs 2,800 per injection, making it the "most economical" brand in the country.
COVID-19: Drug firm Zydus Cadila launches India's cheapest remdesivir version at Rs 2,800Yet again, India witnessed the highest-ever single-day spike of 66,999 new COVID-19 cases the last 24 hours.
Zydus Cadila gets USFDA nod for drug trials to treat chemotherapy-induced anemiaIn a regulatory filing, Zydus Cadila said it has received approval from the US Food and Drug Administration (USFDA) to initiate clinical trials of Desidustat in CIA. Zydus Cadila Chairman Pankaj R..
Seven Indian pharma players race to develop Covid-19 vaccineAt least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already..
Zydus Cadila starts human trials of vaccine
India's Zydus begins human trials for potential Covid-19 vaccineIndian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential Covid-19 vaccine. ZyCoV-D, its plasmid DNA vaccine, was found to be safe, immunogenic and..
Hyd co to start human trials on Covid vaccine soon; Cadila too gets DCGI nod for vaccine trial
Covid-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trialsAfter Bharat Biotech's Covaxin, another potential Covid-19 vaccine indigenously developed by Ahmedabad-based Zydus Cadila Healthcare Ltd got the nod from the Drugs Controller General of India (DCGI) on..
India's Zydus Cadila to make Gilead's potential COVID-19 drug remdesivirIndian drugmaker Zydus Cadila said on Friday it signed a non-exclusive licensing pact with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show..
India's Zydus Cadila signs pact with Gilead to make remdesivirIndian drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in..